Open tender · Germany · Contract notice
Open-House-Biologika-Rabattverträge 2025-25 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)
Techniker Krankenkasse in Germany is inviting bids for “Open-House-Biologika-Rabattverträge 2025-25 - Aflibercept (ATC: S01LA05; Wirkstärke: 40 mg/ml)”. Bids close on 30 November 2026.